logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Astellas Pharma US, Inc. drugs

    FiltersReset Filters
    14 results

    • ambisome - amphotericin b injection, powder, lyophilized, for solution

      (Amphotericin B)
      Astellas Pharma Us, Inc.

    • astagraf xl

      (tacrolimus extended-release capsules)
      Astellas Pharma US, Inc.
      Usage: ASTAGRAF XL® is indicated for the prevention of organ rejection in kidney transplant patients, used in conjunction with other immunosuppressants for both adults and pediatric patients who can swallow capsules intact.

    • cresemba

      (isavuconazonium sulfate)
      Astellas Pharma US, Inc.
      Usage: CRESEMBA is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults and pediatric patients. It is available as an injection for patients aged 1 year and older, and as capsules for those aged 6 years and older who weigh at least 16 kg.

    • izervay

      (avacincaptad pegol)
      Astellas Pharma US, Inc.
      Usage: IZERVAY™ is indicated for the treatment of geographic atrophy (GA) associated with age-related macular degeneration (AMD).

    • lexiscan

      (regadenoson)
      Astellas Pharma US, Inc.
      Usage: LEXISCAN® (regadenoson) injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress.

    • mycamine

      (Micafungin sodium)
      Astellas Pharma US, Inc.
      Usage: MYCAMINE® is indicated for treating candidemia, acute disseminated candidiasis, Candida peritonitis, and esophageal candidiasis in patients 4 months and older. It is also used for prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. Use in pediatric patients under 4 months has limitations.

    • myrbetriq

      (mirabegron)
      Astellas Pharma US, Inc.
      Usage: MYRBETRIQ is indicated for treating adult overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency, either alone or with solifenacin succinate. It is also indicated for pediatric patients (ages 3+) with neurogenic detrusor overactivity (NDO) who weigh 35 kg or more.

    • prograf

      (Tacrolimus)
      Astellas Pharma US, Inc.
      Usage: PROGRAF® is indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic transplants of the kidney, liver, heart, or lung, as part of a regimen with other immunosuppressants.

    • veozah

      (fezolinetant)
      Astellas Pharma US, Inc.
      Usage: VEOZAH® is indicated for treating moderate to severe vasomotor symptoms associated with menopause.

    • vesicare - solifenacin succinate tablet, film coated

      (Solifenacin Succinate)
      Astellas Pharma Us, Inc.